These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 1975100

  • 1. [Plasma anticholinergic activity and cognitive function in geriatric patients].
    Thienhaus OJ, Thoene J, Allen A, Zemlan FP.
    Psychiatr Neurol Med Psychol (Leipz); 1990 May; 42(5):275-81. PubMed ID: 1975100
    [Abstract] [Full Text] [Related]

  • 2. Relation of serum anticholinergicity to cognitive status in schizophrenia patients taking clozapine or risperidone.
    Tracy JI, Monaco CA, Abraham G, Josiassen RC, Pollock BG.
    J Clin Psychiatry; 1998 Apr; 59(4):184-8. PubMed ID: 9590669
    [Abstract] [Full Text] [Related]

  • 3. Screening for cognitive toxicity of anticholinergic drugs.
    Katz IR, Greenberg WM, Barr GA, Garbarino C, Buckley P, Smith D.
    J Clin Psychiatry; 1985 Aug; 46(8):323-6. PubMed ID: 2862135
    [Abstract] [Full Text] [Related]

  • 4. Anticholinergic serum levels and cognitive performance.
    Thienhaus OJ, Allen A, Bennett JA, Chopra YM, Zemlan FP.
    Eur Arch Psychiatry Clin Neurosci; 1990 Aug; 240(1):28-33. PubMed ID: 2147899
    [Abstract] [Full Text] [Related]

  • 5. Replacement of chronically administered anticholinergic drugs by amantadine in outpatient management of chronic schizophrenia.
    McEvoy JP, McCue M, Freter S.
    Clin Ther; 1987 Aug; 9(4):429-33. PubMed ID: 2886223
    [Abstract] [Full Text] [Related]

  • 6. d-Amphetamine: effects on memory in a depressed population.
    Reus VI, Silberman E, Post RM, Weingartner H.
    Biol Psychiatry; 1979 Apr; 14(2):345-56. PubMed ID: 476223
    [Abstract] [Full Text] [Related]

  • 7. Low-level serum anticholinergicity as a source of baseline cognitive heterogeneity in geriatric depressed patients.
    Nebes RD, Pollock BG, Mulsant BH, Kirshner MA, Halligan E, Zmuda M, Reynolds CF.
    Psychopharmacol Bull; 1997 Apr; 33(4):715-20. PubMed ID: 9493484
    [Abstract] [Full Text] [Related]

  • 8. Verbal learning by major depressive disorder patients during treatment with fluoxetine or amitriptyline.
    Richardson JS, Keegan DL, Bowen RC, Blackshaw SL, Cebrian-Perez S, Dayal N, Saleh S, Shrikhande S.
    Int Clin Psychopharmacol; 1994 Apr; 9(1):35-40. PubMed ID: 8195581
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Anticholinergic drugs and physical function among frail elderly population.
    Landi F, Russo A, Liperoti R, Cesari M, Barillaro C, Pahor M, Bernabei R, Onder G.
    Clin Pharmacol Ther; 2007 Feb; 81(2):235-41. PubMed ID: 17192773
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Memory deficits and anticholinergic levels in chronic schizophrenia.
    Perlick D, Stastny P, Katz I, Mayer M, Mattis S.
    Am J Psychiatry; 1986 Feb; 143(2):230-2. PubMed ID: 3946662
    [Abstract] [Full Text] [Related]

  • 13. Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects.
    Altshuler LL, Ventura J, van Gorp WG, Green MF, Theberge DC, Mintz J.
    Biol Psychiatry; 2004 Oct 15; 56(8):560-9. PubMed ID: 15476685
    [Abstract] [Full Text] [Related]

  • 14. [Antidepressive agents and memory].
    Danion JM.
    Encephale; 1993 Jul 15; 19 Spec No 2():417-22. PubMed ID: 8281908
    [Abstract] [Full Text] [Related]

  • 15. Perospirone in the treatment of schizophrenia: effect on verbal memory organization.
    Araki T, Yamasue H, Sumiyoshi T, Kuwabara H, Suga M, Iwanami A, Kato N, Kasai K.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar 15; 30(2):204-8. PubMed ID: 16300872
    [Abstract] [Full Text] [Related]

  • 16. Effect of switching to atypical antipsychotics on memory in patients with chronic schizophrenia.
    Mori K, Nagao M, Yamashita H, Morinobu S, Yamawaki S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jul 15; 28(4):659-65. PubMed ID: 15276691
    [Abstract] [Full Text] [Related]

  • 17. Memory processing with lithium carbonate.
    Marusarz TZ, Wolpert EA, Koh SD.
    J Clin Psychiatry; 1981 May 15; 42(5):190-2. PubMed ID: 7217022
    [Abstract] [Full Text] [Related]

  • 18. Effect of perospirone on P300 electrophysiological activity and social cognition in schizophrenia: a three-dimensional analysis with sloreta.
    Sumiyoshi T, Higuchi Y, Itoh T, Matsui M, Arai H, Suzuki M, Kurachi M, Sumiyoshi C, Kawasaki Y.
    Psychiatry Res; 2009 Jun 30; 172(3):180-3. PubMed ID: 19386475
    [Abstract] [Full Text] [Related]

  • 19. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA, Morrens M, Sabbe BG.
    Clin Ther; 2008 Sep 30; 30(9):1565-89. PubMed ID: 18840365
    [Abstract] [Full Text] [Related]

  • 20. Effects of anticholinergic drug withdrawal on memory, regional cerebral blood flow and extrapyramidal side effects in schizophrenic patients.
    Mori K, Yamashita H, Nagao M, Horiguchi J, Yamawaki S.
    Pharmacopsychiatry; 2002 Jan 30; 35(1):6-11. PubMed ID: 11819152
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.